Literature DB >> 23601754

Implementing guidelines on the prevention of opportunistic infections in inflammatory bowel disease.

A J Walsh1, M Weltman, D Burger, S Vivekanandarajah, S Connor, M Howlett, G Radford-Smith, W Selby, A S Veillard, M C Grimm, S P L Travis, I C Lawrance.   

Abstract

INTRODUCTION: Opportunistic infections are a key safety concern in the management of patients with inflammatory bowel disease (IBD). Despite the existence of international guidelines, many gastroenterologists have not adopted routine screening and vaccination. The aim of this study was to modify clinical behaviour by use of a simple screening tool.
METHODS: A screening and vaccination proforma for hepatitis B, varicella, Influenza, Pneumococcus, human papillomavirus, tuberculosis, hepatitis C and HIV was provided to each participating gastroenterologist. Gastroenterologists were surveyed for awareness of vaccine recommendations and current practice prior to and following the introduction of the proforma. Rates of immunity and the proportion of patients receiving the recommended screening and vaccinations were documented.
RESULTS: 30 gastroenterologists at 8 different IBD centres took part in the assessment. A total of 919 patients were included (55% female, 65% Crohn's, 33% ulcerative colitis, 2% indeterminate IBD). Introduction of the proforma increased self-reported gastroenterologist screening from 47% to 97% pre- and post-intervention respectively, p<0.001. After the proforma was applied, vaccination against hepatitis B, varicella, Influenza, and Pneumococcus was recommended in 67%, 2.5%, 75% and 69% of the patients respectively. Of these, 42%, 39%, 66% and 49% patients followed the recommendations and were vaccinated. Cervical smears were recommended in 31%, with 62% of these obtaining the recommended cervical smear.
CONCLUSIONS: Implementation of a screening and vaccination proforma significantly changed gastroenterologist self-reported behaviour. Patient compliance with these recommendations was not optimal and suggests the need for further patient education, in addition to other forms of support. Crown
Copyright © 2013. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Implementing guidelines; Inflammatory bowel disease; Screening; Vaccination

Mesh:

Substances:

Year:  2013        PMID: 23601754     DOI: 10.1016/j.crohns.2013.02.019

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  16 in total

Review 1.  Quality Improvement in Gastroenterology: A Systematic Review of Practical Interventions for Clinicians.

Authors:  Courtney Reynolds; Eric Esrailian; Daniel Hommes
Journal:  Dig Dis Sci       Date:  2018-07-16       Impact factor: 3.199

2.  Systematic Information to Health-Care Professionals about Vaccination Guidelines Improves Adherence in Patients With Inflammatory Bowel Disease in Anti-TNFα Therapy.

Authors:  Katrine R Christensen; Casper Steenholdt; Sine S Buhl; Mark A Ainsworth; Ole Ø Thomsen; Jørn Brynskov
Journal:  Am J Gastroenterol       Date:  2015-06-02       Impact factor: 10.864

Review 3.  Preventing infective complications in inflammatory bowel disease.

Authors:  Justine Mill; Ian C Lawrance
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 4.  Use of thiopurines in inflammatory bowel disease: Safety issues.

Authors:  Anastasia Konidari; Wael El Matary
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-05-06

5.  Rates and Predictors of Vaccinations Among Inflammatory Bowel Disease Patients Receiving Anti-Tumor Necrosis Factor Agents.

Authors:  Hung-Viet Pham; Imran Hasan; Natalia Udaltsova; Kathy Pham; Oren Abramson; Mary Anne Armstrong; Debbie Postlethwaite; Dan Li
Journal:  Dig Dis Sci       Date:  2017-08-23       Impact factor: 3.199

6.  Guideline recommendations for treatment of patients with inflammatory bowel diseases are not implemented in clinical practice-results of a non-representative survey.

Authors:  Lea I Kredel; Oliver Schneidereit; Jörg C Hoffmann; Britta Siegmund; Jan C Preiß
Journal:  Int J Colorectal Dis       Date:  2018-12-07       Impact factor: 2.571

Review 7.  What is left when anti-tumour necrosis factor therapy in inflammatory bowel diseases fails?

Authors:  Ian C Lawrance
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

8.  Human immunodeficiency virus and liver disease: An update.

Authors:  Kenneth E Sherman; Juergen Rockstroh; David Thomas
Journal:  Hepatology       Date:  2015-10-20       Impact factor: 17.425

9.  Vaccination Rates and Family Barriers Among Children with Inflammatory Bowel Disease.

Authors:  Kathleen J Holland; Tracey A Wilkinson; Erin Phipps; James E Slaven; William E Bennett
Journal:  Crohns Colitis 360       Date:  2020-07-07

Review 10.  Alternative Treatments for Minor GI Ailments.

Authors:  A K Mohiuddin
Journal:  Innov Pharm       Date:  2019-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.